HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3

The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Mesothelin (MSLN).

Saved in:
Bibliographic Details
Main Authors GUSTI ZENG, Veronica, HEDVAT, Michael, DESJARLAIS, John R, BERNETT, Matthew J, FABER, Matthew S
Format Patent
LanguageEnglish
French
German
Published 22.03.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Mesothelin (MSLN).
Bibliography:Application Number: EP20210730426